Scholarly Index
Frank Rigo
Ionis Pharmaceuticals (United States); 19,447 total citations; 203 total publications; best world rank #138
Ionis Pharmaceuticals (United States)
19,447Total citations
203Total publications
65H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Neurogenetic and Muscular Disorders Research | Lifetime | 138 | US 56 | 98.42 |
| RNA modifications and cancer | Lifetime | 858 | US 416 | 98.41 |
| RNA Research and Splicing | Lifetime | 567 | US 337 | 98.40 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 757 | US 177 | 82.43 |
| RNA regulation and disease | 2021-2025 | 712 | US 188 | 73.21 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 928 | US 231 | 77.89 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 998 | US 242 | 74.72 |